Sirukumab

Request For Quotation
Sirukumab Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354;
Email: support@targetmol.com
Products Intro: Product Name:Sirukumab
CAS:1194585-53-9
Package:1mg;288USD|5mg;780USD|10mg;1180USD
Company Name: Aladdin Scientific
Tel:
Email: tp@aladdinsci.com
Products Intro: Product Name:Sirukumab (anti-IL-6)
CAS:1194585-53-9
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:$69.9/100μg;$339.9/1mg;$869.9/5mg;$1379.9/10mg;Bulk package Remarks:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 021-61312847; 18021002903
Email: 3008007409@qq.com
Products Intro: Product Name:Sirukumab (anti-IL-6)
CAS:1194585-53-9
Purity:ExactAb?, Validated, Carrier Free, Low Endotoxin, Azide Free Package:5mg Remarks:K10784
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Sirukumab
CAS:1194585-53-9
Purity:95% Package:100ug;500ug;1mg
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Products Intro: Product Name:Sirukumab
CAS:1194585-53-9
Purity:95% Package:1mg;1g;100g

Sirukumab manufacturers

  • Sirukumab
  • Sirukumab pictures
  • $239.00
  • 2026-05-11
  • CAS:1194585-53-9
  • Purity: 99.37% (SEC-HPLC)
  • Supply Ability: 10g
Sirukumab Basic information
Product Name:Sirukumab
Synonyms:Sirukumab;Research Grade Sirukumab(DHC15803);Sirukumab (anti-IL-6);Research Grade Sirukumab
CAS:1194585-53-9
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Sirukumab Structure
Sirukumab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Sirukumab Usage And Synthesis
UsesSirukumab (CNTO-136) is a humanized monoclonal anti-IL6 (Interleukin Related) IgG1κ antibody. Sirukumab binds to IL6, preventing IL6-mediated signal transduction and activation of transcriptional activators, thereby blocking the downstream biological effects of IL6. Sirukumab can be used in the study of active lupus nephritis and rheumatoid arthritis[1][2].
References[1] Brad H Rovin, et al. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis. Arthritis Rheumatol. 2016 Sep;68(9):2174-83. DOI:10.1002/art.39722
[2] Bartoli F, et al. Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018[J]. Expert Review of Clinical Immunology, 2018, 14(7): 539-547. DOI:10.1080/1744666X.2018.1487291
Sirukumab Preparation Products And Raw materials
Tag:Sirukumab(1194585-53-9) Related Product Information
Cinpanemab Tigatuzumab Volociximab Brodalumab palivizumab Selicrelumab Fresolimumab Balstilimab Teneliximab Brontictuzumab